| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the Treatment of Non–small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab
|
Leventakos, Konstantinos
|
|
2016
|
30 |
5 |
p. 397-405
|
artikel
|
| 2 |
BAY 81-8973 (Octocog Alfa; Kovaltry®): A Review in Haemophilia A
|
Keating, Gillian M.
|
|
|
30 |
5 |
p. 453-459
|
artikel
|
| 3 |
BAY 81-8973 (Octocog Alfa; Kovaltry®): A Review in Haemophilia A
|
Keating, Gillian M.
|
|
2016
|
30 |
5 |
p. 453-459
|
artikel
|
| 4 |
Erratum to: Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases
|
Burness, Celeste B.
|
|
2016
|
30 |
5 |
p. 481
|
artikel
|
| 5 |
Erratum to: Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
|
Nakayamada, Shingo
|
|
2016
|
30 |
5 |
p. 483
|
artikel
|
| 6 |
Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis
|
Zhao, Hongmou
|
|
2016
|
30 |
5 |
p. 387-396
|
artikel
|
| 7 |
Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases
|
Blair, Hannah A.
|
|
2016
|
30 |
5 |
p. 469-480
|
artikel
|
| 8 |
Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
|
Nakayamada, Shingo
|
|
2016
|
30 |
5 |
p. 407-419
|
artikel
|
| 9 |
Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
|
Gerber, Simon
|
|
2016
|
30 |
5 |
p. 441-451
|
artikel
|
| 10 |
Talimogene Laherparepvec: A Review in Unresectable Metastatic Melanoma
|
Garnock-Jones, Karly P.
|
|
2016
|
30 |
5 |
p. 461-468
|
artikel
|
| 11 |
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
|
Skouras, Vasileios S.
|
|
2016
|
30 |
5 |
p. 421-439
|
artikel
|
Tijdschrift beschrijving